Asensus Surgical, Inc. - רווח החברה לפני מסים, ריבית ופחת ASXC

Asensus Surgical, Inc. (ASXC) is strengthening its position by implementing the AI-driven Senhance digital system to expand its B2B segment. Simultaneously, Asensus Surgical, Inc. (ASXC) is reducing the total cost of ownership of its equipment to capture market share, while its operating model is supported by a major partner due to low commercial inertia. Changes in EBITDA_Co confirm an inflow of liquidity, and becomes the new value of the indicator.

For Asensus Surgical, Inc. (ASXC), actual EBITDA reflects the net cash flow from core operations before depreciation and interest, demonstrating the business's real ability to generate profit. The trend of this metric allows for an assessment of the operating model's resilience to microchip supply chain disruptions and export restrictions, serving as an objective measure of resource management efficiency amid geopolitical instability.